Home › Drugs › Tagrisso › Eye side effects
Tagrisso (osimertinib) eye side effects: what to watch for and when to call
If your eyes have felt gritty, watery, or sore since you started Tagrisso (osimertinib), you're right to pay attention. Eye side effects aren't among the most common ones, but the FDA label asks people to report them right away, because the main one, keratitis, is easier to treat when it's caught early. Here's what to look for, what an eye exam involves, and simple ways you and your family can look after your eyes during treatment.
ℹ️ General information to help you and your loved ones talk with your care team, not medical advice. Read our disclaimer.
💌 Free newsletter: gentle updates on side effects, treatments, and help paying for care. You can unsubscribe anytime.
The short version
- The eye side effect named on the Tagrisso label is keratitis (inflammation of the cornea, the clear front window of the eye).
- It's uncommon. In clinical trials it showed up in roughly 4 to 11 of every 1,000 people, depending on the study.
- Warning signs include eye pain, redness, watering, light sensitivity, and blurry or changed vision.
- Call your cancer care team the same day. They may send you to an ophthalmologist (a medical doctor who treats eyes).
Why a lung cancer pill can affect your eyes
Tagrisso is an EGFR inhibitor (a pill that blocks the EGFR growth signal) used for EGFR-mutated non-small cell lung cancer. Cancer cells with an EGFR mutation depend on that signal, which is why the drug works. Healthy cells in the skin, nails, gut lining, and the surface of the eye use EGFR too. That's why the most common Tagrisso side effects show up in places like the skin and nails, and why the eye surface can sometimes be affected. A nursing review in JADPRO lists eye problems among the side effects seen across this whole drug class.
What the FDA label says
The Tagrisso prescribing information (updated September 2026) lists keratitis in its Warnings and Precautions section. Across 1,813 people who took Tagrisso alone in clinical trials, keratitis was reported in 0.6%. Here's how often it showed up in each of the main studies:
| Study | Who was in it | Keratitis |
|---|---|---|
| ADAURA | After surgery for early-stage lung cancer | 0.6% |
| LAURA | Stage III, after chemoradiation | 0.7% |
| FLAURA | First treatment for metastatic cancer | 0.4% |
| FLAURA2 | Tagrisso given with chemo | 0.7% |
| AURA3 | After an earlier EGFR pill (T790M mutation) | 1.1% |
Numbers come from the Adverse Reactions section of the FDA label. They describe groups of people in studies, not your personal risk.
What keratitis can feel like
The cornea is the clear dome over the colored part of your eye. It's packed with nerves, which is why even a small problem there can hurt. The label and its patient information list these signs:
- Eye pain, or a feeling that something is stuck in your eye
- Red or bloodshot eyes
- Lacrimation (watery eyes, or extra tearing)
- Photophobia (light sensitivity), when normal light feels too bright
- Blurry vision, or any change in how you see
Some of these overlap with dry eye, allergies, or a passing irritation, and it's hard to tell them apart at home. That's the reason to call rather than wait and guess. Eye symptoms are worth a call even if you've been on Tagrisso for a long time without any trouble.
What happens at the eye doctor
If your team thinks you could have keratitis, the label advises a prompt referral to an ophthalmologist. The visit is usually quick and painless. According to the American Academy of Ophthalmology, the doctor may put a drop of orange-yellow dye (fluorescein) in your eye and look through a slit lamp (a microscope with a bright light) to spot any damage on the surface of the cornea. If an infection is possible, they may take a tiny sample to test.
Treatment depends on the cause. It may include lubricating drops, prescription drops for inflammation or infection, and advice about contact lenses. Bring your medicine list, including Tagrisso, so the eye doctor knows you take an EGFR inhibitor. Your oncologist and eye doctor will decide together whether Tagrisso needs a short pause while your eye heals. Please don't stop or skip doses on your own.
Dry, gritty, or irritated eyes
Not every eye complaint during treatment is keratitis. Cancer Research UK notes that some targeted drugs and chemo drugs can leave eyes dry, sore, or gritty, sometimes even while they water. The National Cancer Institute (NCI) explains that some cancer treatments can cause dry eye syndrome (when your eyes don't make enough tears), and that prescription drops or ointments can help.
Tell your team about dryness too, even if it's mild. Ask before using any eye drops, including ones from the drugstore, so they can suggest a type that fits your situation.
🏠 Everyday eye care during treatment
- Wash your hands before touching your eyes, putting in drops, or handling contact lenses.
- If you wear contacts, follow your eye doctor's cleaning routine closely, and never sleep in them. The American Academy of Ophthalmology warns that contact lens wearers are more likely to get infections of the cornea.
- Keep a pair of glasses handy so you can rest your eyes when they feel irritated.
- Wear sunglasses outdoors if light bothers you, and a brimmed hat on bright days.
- Use a humidifier if the air at home is dry, and take screen breaks to blink and rest your eyes.
- Try not to rub your eyes. If the skin around your eyes is dry or has a rash, ask your team which creams are safe to use near the eyes.
- Keep up with regular eye exams, and tell every eye doctor that you take Tagrisso (osimertinib).
Call your care team the same day if you have:
- Eye pain or a feeling that something is in your eye
- A red eye that doesn't clear up
- A lot of watering or new light sensitivity
- Blurry vision or any change in how you see
Get emergency care for a sudden loss of vision or sudden, severe eye pain.
💜 How loved ones can help
- Notice if they squint, rub their eyes, or avoid bright rooms, and gently ask how their eyes feel.
- Offer to drive to the eye appointment, since eye drops used during the exam can blur vision for a few hours.
- Help keep a symptom note with dates, and take a photo of a red eye to show the team.
- Pick up sunglasses or a brimmed hat as a small, practical gift.
Other Tagrisso side effects to know about
Eye problems are only one part of the picture. The most common Tagrisso side effects are diarrhea, rash, muscle and bone aches, nail changes, dry skin, mouth sores, and tiredness. Our main Tagrisso (osimertinib) guide covers each one with home tips and help paying. If you've been taking it for a while, our guide to Tagrisso long-term side effects explains which effects tend to ease and which checkups continue.
Questions people often ask
Can Tagrisso cause blurry vision?
Yes, it can. Blurry vision or any change in how you see is one of the warning signs of keratitis (eye surface inflammation) listed on the Tagrisso label. Blurry vision can have other causes too, so call your care team and let them sort it out.
How common are eye problems with Tagrisso?
Uncommon. In clinical trials, keratitis was reported in 0.6% of 1,813 people who took Tagrisso (osimertinib) alone, or about 6 in 1,000. Individual studies ranged from 0.4% to 1.1%.
Can I wear contact lenses while taking Tagrisso?
The label doesn't say you must stop. Ask your eye doctor what's best for you, keep your lenses very clean, never sleep in them, and switch to glasses and call your team if an eye becomes painful, red, or sensitive to light.
Do Tagrisso eye side effects go away?
Keratitis is usually treated by an eye doctor with drops and close follow-up. Early care gives the best chance of healing well, which is why the label asks you to report eye symptoms right away.
Should I use over-the-counter eye drops?
Ask first. Your care team or eye doctor can suggest lubricating drops that suit you. Some drops aren't right for an eye that might be inflamed or infected.
💌 Get gentle, helpful updates
A free email now and then with new guides on side effects, treatments, and help paying for care. No medical advice, and we never ask about your health. You'll get a short email to confirm, and you can unsubscribe anytime.
Or sign up here. Our newsletter is sent by Beehiiv, and tapping the button loads their form. Please don't share health details. See our privacy policy.
Written by the CSE Team from FDA labels and leading cancer centers. Not medical advice. · Last updated: October 15, 2026 · How we write
Sources
Last updated: October 15, 2026. We summarize these sources in our own words.
- FDA label (DailyMed, Sep 2026): Tagrisso (osimertinib)
- American Academy of Ophthalmology: What Is a Corneal Ulcer (Keratitis)?
- American Academy of Ophthalmology: Eye Infections From Contact Lenses
- Cancer Research UK: Your eyes and cancer drugs
- NCI: Late Effects of Cancer Treatment
- JADPRO: Management Strategies for Adverse Events Associated With EGFR TKIs in Non-Small Cell Lung Cancer